Publication: 4637

Timing of Adjuvant Chemotherapy and Circulating Tumor DNA (ctDNA) Status is Associated with Survival after Resection of Stage III Colon Cancer: Results from CALGB (Alliance)/SWOG 80702
Google Scholar   
Citation:
Meeting Instance:
ACS CC 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
4691   4738   4842  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
U10CA180821, U10CA180882, U24CA196171; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                     
Networks:
LAPS-IL057, LAPS-MA036, LAPS-MO011, OH027   
Study
CALGB-80702
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: